Albiglutide - Wikipedia
WEBAlbiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK) for treatment of type 2 diabetes. As of 2017 it is unclear if it affects a person's risk of death. [2]
Albiglutide: Indications, Side Effects, Warnings - Drugs.com
WEBApr 15, 2024 · Easy-to-read patient leaflet for Albiglutide. Includes indications, proper use, special instructions, precautions, and possible side effects.
Tanzeum: Uses, Dosing, Side Effects & Warnings - Drugs.com
WEBMay 1, 2024 · Tanzeum (albiglutide) is used to treat Type 2 Diabetes. Includes Tanzeum side effects, interactions and indications.
Albiglutide: Uses, Interactions, Mechanism of Action - DrugBank …
WEBApr 28, 2015 · Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is marketed under the brands Eperzan and Tanzeum by GSK (GlaxoSmithKline). It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin.
Tanzeum (albiglutide) dosing, indications, interactions, adverse ...
WEBGlucagonlike peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 30 mg SC once weekly; may increase...
Albiglutide (Subcutaneous Route) - Mayo Clinic
WEBMay 1, 2024 · Albiglutide injection is used to treat type 2 diabetes mellitus. Albiglutide is used together with diet and exercise to help control your blood sugar. This medicine is available only with your doctor's prescription.
Albiglutide and cardiovascular outcomes in patients with type 2 ...
WEBIn patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 ...
Albiglutide (Professional Patient Advice) - Drugs.com
WEBProfessional guide for Albiglutide. Includes: pharmacology, pharmacokinetics, contraindications, interactions and adverse reactions.
Albiglutide: a unique GLP-1 receptor agonist - PubMed
WEBAlbiglutide is a long acting GLP-1 receptor agonist (GLP-1 RA) administered by weekly injection. Area covered: The pharmacokinetic and pharmacodynamic properties of albiglutide and its clinical effects are discussed.
Albiglutide: A New GLP-1 Receptor Agonist Option - National …
WEBThe FDA approval of albiglutide has added a new once-weekly treatment option as an adjunct to diet and exercise for the treatment of patients with type 2 diabetes. Albiglutide is a GLP-1 receptor agonist administered via an injection pen once weekly.